251 related articles for article (PubMed ID: 15675721)
1. Depression and Parkinson's disease.
Lemke MR; Fuchs G; Gemende I; Herting B; Oehlwein C; Reichmann H; Rieke J; Volkmann J
J Neurol; 2004 Sep; 251 Suppl 6():VI/24-7. PubMed ID: 15675721
[TBL] [Abstract][Full Text] [Related]
2. Depressive symptoms in Parkinson's disease.
Lemke MR
Eur J Neurol; 2008 Apr; 15 Suppl 1():21-5. PubMed ID: 18353133
[TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease.
Richard IH; McDermott MP; Kurlan R; Lyness JM; Como PG; Pearson N; Factor SA; Juncos J; Serrano Ramos C; Brodsky M; Manning C; Marsh L; Shulman L; Fernandez HH; Black KJ; Panisset M; Christine CW; Jiang W; Singer C; Horn S; Pfeiffer R; Rottenberg D; Slevin J; Elmer L; Press D; Hyson HC; McDonald W;
Neurology; 2012 Apr; 78(16):1229-36. PubMed ID: 22496199
[TBL] [Abstract][Full Text] [Related]
4. Prevalence, clinical manifestations, etiology, and treatment of depression in Parkinson's disease.
Slaughter JR; Slaughter KA; Nichols D; Holmes SE; Martens MP
J Neuropsychiatry Clin Neurosci; 2001; 13(2):187-96. PubMed ID: 11449025
[TBL] [Abstract][Full Text] [Related]
5. Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
Barone P; Poewe W; Albrecht S; Debieuvre C; Massey D; Rascol O; Tolosa E; Weintraub D
Lancet Neurol; 2010 Jun; 9(6):573-80. PubMed ID: 20452823
[TBL] [Abstract][Full Text] [Related]
6. Effect of reboxetine on depression in Parkinson's disease patients.
Lemke MR
J Clin Psychiatry; 2002 Apr; 63(4):300-4. PubMed ID: 12000202
[TBL] [Abstract][Full Text] [Related]
7. Beyond the iron mask: towards better recognition and treatment of depression associated with Parkinson's disease.
Burn DJ
Mov Disord; 2002 May; 17(3):445-54. PubMed ID: 12112190
[TBL] [Abstract][Full Text] [Related]
8. Treatment of depressive symptoms in Parkinson's disease.
Barone P
Eur J Neurol; 2011 Mar; 18 Suppl 1():11-5. PubMed ID: 21255198
[TBL] [Abstract][Full Text] [Related]
9. Treatment options for depression and psychosis in Parkinson's disease.
Poewe W; Seppi K
J Neurol; 2001 Sep; 248 Suppl 3():III12-21. PubMed ID: 11697683
[TBL] [Abstract][Full Text] [Related]
10. [Antidepressant effects of dopamine agonists. Experimental and clinical findings].
Lemke MR
Nervenarzt; 2007 Jan; 78(1):31-8. PubMed ID: 17187269
[TBL] [Abstract][Full Text] [Related]
11. Antidepressants for Depression, Apathy, and Gait Instability in Parkinson's Disease: A Multicenter Randomized Study.
Takahashi M; Tabu H; Ozaki A; Hamano T; Takeshima T;
Intern Med; 2019 Feb; 58(3):361-368. PubMed ID: 30146591
[TBL] [Abstract][Full Text] [Related]
12. [Selective serotonin reuptake inhibitors and newer antidepressive substances in child and adolescent psychiatry].
Heiser P; Remschmidt H
Z Kinder Jugendpsychiatr Psychother; 2002 Aug; 30(3):173-83. PubMed ID: 12227220
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of atypical antipsychotics in depressive syndromes].
Quintin P; Thomas P
Encephale; 2004; 30(6):583-9. PubMed ID: 15738862
[TBL] [Abstract][Full Text] [Related]
14. [Depression in Parkinson's disease].
Defebvre L
Presse Med; 2009 Jun; 38(6):869-71. PubMed ID: 19162435
[No Abstract] [Full Text] [Related]
15. The role of dopamine agonists in the treatment of depression in patients with Parkinson's disease: a systematic review.
Leentjens AF
Drugs; 2011 Feb; 71(3):273-86. PubMed ID: 21319866
[TBL] [Abstract][Full Text] [Related]
16. Depression in Parkinson's disease.
Brandstädter D; Oertel WH
Adv Neurol; 2003; 91():371-81. PubMed ID: 12442696
[No Abstract] [Full Text] [Related]
17. [Depression in Parkinson's disease--Part 2: Therapy and management].
Storch A; Schneider C; Ebersbach G; Fuchs G; Jost WH; Odin P; Reifschneider G; Bauer M
Fortschr Neurol Psychiatr; 2010 Aug; 78(8):456-67. PubMed ID: 20694938
[TBL] [Abstract][Full Text] [Related]
18. Depression in patients with Parkinson's disease.
Cummings JL; Masterman DL
Int J Geriatr Psychiatry; 1999 Sep; 14(9):711-8. PubMed ID: 10479741
[TBL] [Abstract][Full Text] [Related]
19. Psychiatric aspects of Parkinson's disease--an update.
Schrag A
J Neurol; 2004 Jul; 251(7):795-804. PubMed ID: 15258780
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological interventions for anxiety in Parkinson's disease sufferers.
Sawada H; Umemura A; Kohsaka M; Tomita S; Park K; Oeda T; Yamamoto K
Expert Opin Pharmacother; 2018 Jul; 19(10):1071-1076. PubMed ID: 29939821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
